DekaBank Deutsche Girozentrale - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 220 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$66
+13.8%
3,7240.0%0.00%
Q1 2024$58
-94.3%
3,724
-91.1%
0.00%
-100.0%
Q2 2023$1,013
+66.6%
42,0000.0%0.00%0.0%
Q1 2023$60842,0000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 10,451,241$157,186,66542.99%
M28 Capital Management LP 339,500$5,106,0805.77%
Ghost Tree Capital, LLC 1,100,000$16,544,0004.89%
Soleus Capital Management, L.P. 750,300$11,284,5121.17%
Parkman Healthcare Partners LLC 275,641$4,145,6410.90%
683 Capital Management, LLC 775,000$11,656,0000.87%
Leucadia National 5,100,110$76,705,6540.62%
Pier Capital, LLC 233,472$3,511,4190.53%
Harvest Investment Services, LLC 40,729$612,5640.47%
Artal Group S.A. 511,389$7,6910.46%
View complete list of TG THERAPEUTICS INC shareholders